FDA COVID-19 Vaccine Process Is 'Thoughtful And Deliberate,' Says Former FDA Head

  • 📰 NPRHealth
  • ⏱ Reading Time:
  • 37 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 18%
  • Publisher: 63%

United States Headlines News

United States Latest News,United States Headlines

Rachel Martin speaks with former Food and Drug Administration commissioner Dr. Mark McClellan about this week's FDA advisory panel on COVID-19 vaccine research.

that after Thursday's advisory meeting, Americans should feel confident in the FDA's approach toward a vaccine.

McClellan predicted that early availability for a vaccine might come later this year with large-scale access in the spring or summer. He is on the board of Johnson & Johnson, which is working on a COVID-19 vaccine.How do you begin to bridge that trust gap [for people who don't trust the expedited process]?

I think what's different here is that there is so much at stake. This is a vaccine that would be potentially used by tens, hundreds of millions of Americans to help us get out of the pandemic and it's also occurring at a time when there's been a lot of politics involved.

So there will be lots of vaccine available — not for everybody, but for lots of doses when these trials are done. ...

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 144. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Former FDA Commissioner Discusses Updates On COVID-19 Vaccine Research EffortsRachel Martin speaks with former Food and Drug Administration commissioner Dr. Mark McClellan about this week's FDA advisory panel on COVID-19 vaccine research.
Source: NPRHealth - 🏆 144. / 63 Read more »

FDA extends Covid-19 vaccine meeting to allow public inputThe FDA has added extra time to a daylong meeting Thursday of its vaccine advisers. The meeting will now include at least an hour and a half for public input, according to an agenda posted online. 2000: Vaccine skepticism is cool. 2010: Vaccine skepticism is anti-science. 2020: Vaccine skepticism is woke. Amazing to see the battle between big pharma creating the narrative of 'anti-vaxxers' being anti-science and Democrats claiming to be for science but anti-covid vaccine. Whatever they added are useless, America had a crazy selfish president, you just need to remove this Donald Trump, guaranteed America back to normal.
Source: CNN - 🏆 4. / 95 Read more »

FDA Approves Remdesivir to Treat COVID-19The pharmaceutical company Gilead Sciences announced that the FDA has approved the antiviral drug remdesivir for treating COVID-19, the company said Thursday in a news release. What you need to know:
Source: WebMD - 🏆 709. / 51 Read more »

Bet against 25 stocks on successful COVID-19 vaccine, JPMorgan says - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web.
Source: BusinessInsider - 🏆 729. / 51 Read more »

WSJ News Exclusive | Covid-19 Vaccine Trial From AstraZeneca, Oxford Can Resume in U.S.Covid-19 vaccine trial From AstraZeneca PLC and the University of Oxford can resume in U.S., according to a person familiar with the matter. So who wants to die next? ‘According the the person familiar with the matter ‘...alright then. Convenient pump
Source: WSJ - 🏆 98. / 63 Read more »

AstraZeneca will resume its Covid-19 vaccine trial in the USThe coronavirus pandemic has brought countries to a standstill. In many places, as countries reopen, Covid-19 cases are on the rise. Follow here for the latest. Yeah realdonaldtrump - rounding the curve to funeral homes
Source: CNN - 🏆 4. / 95 Read more »